ACR 3.57% 5.8¢ acrux limited

FDA questions efficacy of testosterone and whether risks really do exist, page-4

  1. 11,201 Posts.
    lightbulb Created with Sketch. 697
    So what about insurers in the US - with insurance a testosterone treatment is about $97 pcm, and without about $440 pcm from one source. http://www.drugs.com/comments/testosterone/
    Big diff. Might insurers not tighten requirements for insurance coverage? Could be an earnings risk before any study is completed, as they may only cover for hypogonadism. Maybe that is all they cover ATM anyway?
    Not sure what proportion of patients is getting the insured price.

    If anybody knows a bit about the insurance angle - would love to hear it.

    cheers
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.